APA
Baig H., Somlo B., Eisen M., Stryker S., Bensink M. & Morrow P. K. (20191128). Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Chicago
Baig Hassam, Somlo Barbara, Eisen Melissa, Stryker Scott, Bensink Mark and Morrow Phuong K. 20191128. Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Harvard
Baig H., Somlo B., Eisen M., Stryker S., Bensink M. and Morrow P. K. (20191128). Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
MLA
Baig Hassam, Somlo Barbara, Eisen Melissa, Stryker Scott, Bensink Mark and Morrow Phuong K. Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20191128.